Skip to main content
Year archive

ACRUX LIMITED — 2025 filings

All 71 regulatory filings released by ACRUX LIMITED (ACR) in 2025, sourced directly from the official regulator.

71 Filings
2025 Period
2025 filings (71)
Filing Released Lang
Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream 1
Capital/Financing Update
2025-12-11 English
Notification regarding unquoted securities - ACR 6 pages 19.2KB
Share Issue/Capital Change
2025-12-02 English
Appendix 3Y Dobinson 2 pages 195.2KB
Director's Dealing
2025-12-02 English
Appendix 3Y Brumley 2 pages 234.6KB
Director's Dealing
2025-12-02 English
Appendix 3Y Oldham 2 pages 236.0KB
Director's Dealing
2025-12-02 English
Appendix 3Y Brooke 2 pages 219.0KB
Director's Dealing
2025-12-02 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Regulatory Filings
2025-12-02 English
Notification regarding unquoted securities - ACR 7 pages 22.0KB
Share Issue/Capital Change
2025-12-02 English
Appendix 3Y Warmbrunn 2 pages 232.7KB
Director's Dealing
2025-12-02 English
AGM Presentation and Address 15 pages 3.4MB
AGM Information
2025-11-24 English
Results of Annual General Meeting 2 pages 131.7KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-24 English
Application for quotation of securities - ACR 5 pages 16.6KB
Share Issue/Capital Change
2025-11-23 English
Appendix 3Y Brumley 2 pages 234.6KB
Director's Dealing
2025-11-23 English
Appendix 3Y Oldham 2 pages 235.7KB
Director's Dealing
2025-11-23 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Regulatory Filings
2025-11-23 English
Acrux receives $0.4m advance on FY26 R&D Tax Incentive 1
Capital/Financing Update
2025-11-12 English
Updated September Quarter Activities Statement and App4C 8 pages 392.8KB
Interim / Quarterly Report
2025-11-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 312.1KB
Interim / Quarterly Report
2025-10-30 English
Notice of Annual General Meeting/Proxy Form 16 pages 595.4KB
AGM Information
2025-10-23 English
Notification of AGM date and nomination of directors 1
AGM Information
2025-09-29 English
Notification regarding unquoted securities - ACR 6 pages 18.4KB
Share Issue/Capital Change
2025-09-21 English
Received $3.04m RDTI rebate for FY25 1 page 124.7KB
Capital/Financing Update
2025-09-03 English
Appendix 4E and Full Year Statutory Accounts FY25 74 pages 9.0MB
Annual Report
2025-08-28 English
Appendix 4G and Corporate Governance Statement FY25 25 pages 636.2KB
Governance Information
2025-08-28 English
Licensing partnership in Saudi Arabia for Dapsone 5%, Gel 2 pages 178.0KB
Capital/Financing Update
2025-07-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 368.1KB
Interim / Quarterly Report
2025-07-29 English
Application for quotation of securities - ACR 5 pages 16.6KB
Share Issue/Capital Change
2025-07-02 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Share Issue/Capital Change
2025-07-02 English
Receipt of second advance for FY25 R&D Tax Incentive 1
Capital/Financing Update
2025-07-02 English
Change in substantial holding 3 pages 332.2KB
Major Shareholding Notification
2025-06-29 English
App 3X, Warmbrunn 2 pages 246.5KB
Director's Dealing
2025-06-01 English
App 3Z, Kotsanis 2 pages 295.5KB
Director's Dealing
2025-06-01 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Regulatory Filings
2025-05-22 English
Application for quotation of securities - ACR 5 pages 16.6KB
Share Issue/Capital Change
2025-05-22 English
Appendix 3Y Brumley 2 pages 236.5KB
Director's Dealing
2025-05-22 English
Dapsone 7.5%, Gel launched in the United States 2 pages 160.5KB
Regulatory Filings
2025-05-08 English
Acrux CEO and Managing Director appointment 3 pages 167.2KB
Board/Management Information
2025-05-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 293.0KB
Interim / Quarterly Report
2025-04-29 English
Details of Share Registry address 1 page 123.8KB
Regulatory Filings
2025-04-08 English
Application for quotation of securities - ACR 6 pages 18.2KB
Capital/Financing Update
2025-04-03 English
Appendix 3Y Dobinson 2 pages 196.5KB
Director's Dealing
2025-04-03 English
Acrux receives $1.73m advance on FY25 R&D Tax Incentive 1
Capital/Financing Update
2025-04-02 English
Attaching Options final application date 31 March 2025 1
Capital/Financing Update
2025-03-06 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Regulatory Filings
2025-03-05 English
Appendix 3Y Dobinson 2 pages 197.0KB
Director's Dealing
2025-03-03 English
Application for quotation of securities - ACR 6 pages 18.1KB
Share Issue/Capital Change
2025-03-02 English
Cleansing Notice 1 page 141.2KB
Capital/Financing Update
2025-03-02 English
Appendix 4D and December 2024 Half Year Accounts 19 pages 986.6KB
Interim / Quarterly Report
2025-02-24 English
Investor Webinar Announcement 2 pages 107.5KB
Investor Presentation
2025-02-24 English
Investor Presentation February 2025 19 pages 2.1MB
Investor Presentation
2025-02-24 English
Issue of Attaching Options initiated, extended Closing Date 1
Capital/Financing Update
2025-02-18 English
Application for quotation of securities - ACR 7 pages 21.6KB
Share Issue/Capital Change
2025-02-18 English
Appendix 3Y Brumley 2 pages 236.5KB
Director's Dealing
2025-02-18 English
Appendix 3Y Brooke 2 pages 221.7KB
Director's Dealing
2025-02-18 English
Appendix 3Y Kotsanis 2 pages 214.2KB
Director's Dealing
2025-02-18 English
Appendix 3Y Oldham 2 pages 237.9KB
Director's Dealing
2025-02-18 English
Top20 quoted option holders and distribution schedule 6 pages 136.0KB
Major Shareholding Notification
2025-02-18 English
Application for quotation of securities - ACR 7 pages 19.5KB
Share Issue/Capital Change
2025-02-17 English
Notification regarding unquoted securities - ACR 6 pages 18.4KB
Share Issue/Capital Change
2025-02-17 English
Appendix 3Y x 4 8 pages 387.7KB
Director's Dealing
2025-02-12 English
Cleansing Notice 1 page 141.1KB
Regulatory Filings
2025-02-12 English
Application for quotation of securities - ACR 6 pages 18.4KB
Capital/Financing Update
2025-02-12 English
Cleansing Notice - Reissued 1 page 141.0KB
Director's Dealing
2025-02-12 English
Acrux CEO announces plan to retire 2 pages 106.5KB
Board/Management Information
2025-02-06 English
Results of EGM 2 pages 190.2KB
Declaration of Voting Results & Voting Rights Announcements
2025-02-02 English
Monthly Activities/Appendix 4C Cash Flow Report 7 pages 307.9KB
Interim / Quarterly Report
2025-01-29 English
Update - Proposed issue of securities - ACR 5 pages 19.7KB
Capital/Financing Update
2025-01-20 English
Prospectus - Options 41 pages 801.0KB
Capital/Financing Update
2025-01-16 English
Target Market Determination - Options 6 pages 201.8KB
Regulatory Filings
2025-01-16 English
Launch of 90 gram pack size of Dapsone 5%, Gel in US 2 pages 121.5KB
Regulatory Filings
2025-01-15 English
Notice of Extraordinary General Meeting/Proxy Form 30 pages 607.5KB
Proxy Solicitation & Information Statement
2025-01-02 English